- Sustainability
- DE&I
- Pandemic
- Finance
- Legal
- Technology
- Regulatory
- Global
- Pricing
- Strategy
- R&D/Clinical Trials
- Opinion
- Executive Roundtable
- Sales & Marketing
- Executive Profiles
- Leadership
- Market Access
- Patient Engagement
- Supply Chain
- Industry Trends
Fougera celebrates 150th anniversary
E. Fougera & Co. will celebrate its sesquicentennial this year, the Long Island, NY-based generic pharmaceuticals company announced.
E. Fougera & Co. will celebrate its sesquicentennial this year, the Long Island, NY-based generic pharmaceuticals company announced.
The company kicked off its celebration by donating two $2,500 grants to pharmacy degree programs at two local colleges, The Arnold and Marie Schwartz College of Pharmacy at Long Island University and the College of Pharmacy and Allied Health Professionals at St. John's University. The gifts will be used to support students who demonstrate academic achievement, financial need and service to the profession and/or the community.
The company, one of Long Island's largest employers, has always had local ties. Edmond Fougera, a French immigrant, founded it in Brooklyn in 1849. His business began as a pharmacy specializing in European imports and was the first pharmacy to introduce Americans to petroleum jelly.
By 1918, it developed a reputation as the country's "largest wholesale importing house for French and other foreign medicinal preparations and specialties," according to a 1918 article in The Brooklyn Eagle, the local news rag.
In the 1930s and 1940s, Fougera began specializing in the dermatological and urological markets, and it deployed a national sales force. By 1963, the company had attracted the attention of a German company called Byk Gulden GMBH, and the German company acquired Fougera. In 1966, the company entered the generic pharmaceutical market.
Over the course of the past 30 years, Fougera has focused on manufacturing and selling generic creams and ointments, such as Surgilube, Diflorasone Diacetate Cream, Hydrocortisone Rx and Vitamin A & D Ointment. Five of its products are ranked first in market share.
"If you open your medicine cabinet, chances are you will find a Fougera product right there on the shelf," said Stuart Schansinger, the company's buying group sales manager. "We are extremely proud of what we have achieved over our long history, from our roots as a retail pharmacy to our present role as a major generic pharmaceutical manufacturer." PR
The Transformative Role of Medical Information in Customer Engagement
October 3rd 2024Stacey Fung, Head of Global Medical Information at Gilead Lifesciences, delves into the evolving role of Medical Information (MI) in the pharmaceutical industry. Covering key topics like patient engagement through omnichannel strategies, combating misinformation, and leveraging AI to enhance medical inquiries, the conversation with Stacey highlights MI's critical role in ensuring patient safety and supporting drug development. She also shares her professional journey and tidbits for early career professionals on professional development.
Unlocking value and cost savings in patient services with technology and talent
October 2nd 2024Traci Miller, Director, Sonexus™ Access and Patient Support, Cardinal Health, discusses the current digital trends in the patient services industry and how the optimal balance of technology and talent can transform manufacturer-sponsored patient support programs. Hear how Cardinal Health combines best-in-class program and pharmacy operations with smart digital tools to ensure product and patient success and reduce operational costs.
